Endocrine disruptors and human reproductive failure: the in vitro effect of phthalates on human luteal cells  Federica Romani, M.D., Anna Tropea, M.D.,

Slides:



Advertisements
Similar presentations
Elias M. Dahdouh, M. D. , M. Sc. , Jacques Balayla, M. D
Advertisements

Is the type of gonadotropin-releasing hormone suppression protocol for ovarian hyperstimulation associated with ectopic pregnancy in fresh autologous.
Study of nucleation status in the second cell cycle of human embryo and its impact on implantation rate  Jesus Aguilar, Ph.D., Irene Rubio, Ph.D., Elkin.
A giant oocyte in a cohort of retrieved oocytes: does it have any effect on the in vitro fertilization cycle outcome?  Ronit Machtinger, M.D., Joseph.
Seven roads traveled well and seven to be traveled more
Akanksha Mehta, M.D., Mark Sigman, M.D.  Fertility and Sterility 
The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition  Lorraine Dennerstein,
Fernando Zegers-Hochschild, M.D.  Fertility and Sterility 
Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin- releasing hormone receptor antagonist in healthy women with normal ovulation.
Bjørn Bay, M. D. , Erik Lykke Mortensen, M. Sc
Michael M. Alper, M.D.  Fertility and Sterility 
Composition of single-step media used for human embryo culture
The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation.
Ovarian pregnancy after in vitro fertilization
Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study  Nicole Hope, M.B., B.S., Hon., Luk.
Federica Romani, M. D. , Antonio Lanzone, M. D. , Anna Tropea, M. D
Effect of the oxytocin antagonist antocin and agonist decomoton on baboon luteal cell production and release of progesterone  M. Yusoff Dawood, M.D.,
Medical treatment of ectopic pregnancy: a committee opinion
The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society.
Transforming growth factor (TGF)-β1-induced human endometrial stromal cell decidualization through extracellular signal-regulated kinase and Smad activation.
How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.
Improvement of in vitro culture of mouse cumulus–oocyte complexes using PDE3- inhibitor followed by meiosis induction with epiregulin  Sergio Romero, M.Sc.,
Martin D. Keltz, M. D. , Josh C. Skorupski, M. D. , Katrina Bradley, M
Oocyte cryopreservation
Establishing a human chorionic gonadotropin cutoff to guide methotrexate treatment of ectopic pregnancy: a systematic review  Seema Menon, M.D., John.
Robert F. Casper, M.D.  Fertility and Sterility 
Mieke Carine Wim Eeckhaut, Ph.D.  Fertility and Sterility 
Looking back: egg donors' retrospective evaluations of their motivations, expectations, and experiences during their first donation cycle  Nancy J. Kenney,
Prokineticin 1, homeobox A10, and progesterone receptor messenger ribonucleic acid expression in primary cultures of endometrial stromal cells isolated.
Rahi Victory, M. D. , F. R. C. S. C. , Ghassan M. Saed, Ph. D
Estrogens and androgens affect human luteal cell function
A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization  Laura Detti, M.D., Daniel B. Williams, M.D., Jared.
Ultrashort flare gonadotropin-releasing hormone (GnRH) agonist/GnRH antagonist protocol: a valuable tool in the armamentarium of ovulation induction for.
A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone 
Psoriatic patients have an increased risk of polycystic ovary syndrome: results of a cross-sectional analysis  Francesca Moro, M.D., Clara De Simone,
Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility  Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,
Clomiphene citrate at 50: the dawning of assisted reproduction
Modulation of HOXA10 and other markers of endometrial receptivity by age and human chorionic gonadotropin in an endometrial explant model  Robin H. Fogle,
Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D. 
Activin-A is induced by interleukin-1β and tumor necrosis factor-α and enhances the mRNA expression of interleukin-6 and protease-activated receptor-2.
Young-Hoon Kim, M. D. , Ph. D. , Sung Hoon Kim, M. D. , Ph. D
Ri-Cheng Chian, Ph.D., Peter S. Uzelac, M.D., Geeta Nargund, M.D. 
Jcoe Glenn Proctor, B.S., William R. Boone, Ph.D. 
P-425 Fertility and Sterility Volume 86, Issue 3, (September 2006)
Roberto Ensenat-Waser, Ph. D. , Antonio Pellicer, M. D. , Ph. D
Cameron Gilbert, M. Sc. , Maria Valois, M. D. , FRCPC, Ph. D
S. Samuel Kim, M.D.  Fertility and Sterility 
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
Human granulosa-lutein cell in vitro production of progesterone, inhibin A, inhibin B, and activin A are dependent on follicular size and not the presence.
L. Scott, J. Bernsten, K. DeLegge, J. Hill, N. Ramsing 
Prokineticin 1 mRNA expression in the endometrium of healthy women and in the eutopic endometrium of women with endometriosis  Federica Tiberi, B.S.,
Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization  David W. Schmidt, M.D.,,
Fertility and Sterility: an evaluation
Miguel Angel Brieño-Enríquez, M. D. , Ph. D. , Eduardo Larriba, Ph. D
Upregulation of mRNA expression of vascular endothelial growth factor and its receptors by exogenous human chorionic gonadotropin in cultured oviduct.
Counteraction during movement of spermatozoa by Trichomonas vaginalis observed by visual image analysis: a possible cause of female infertility  Viroj.
Current evaluation of amenorrhea
Fertility and Sterility
Direct injection of vascular endothelial growth factor into the ovary of mice promotes follicular development  Ramiro Quintana, M.D., Laura Kopcow, M.D.,
David H. Barad, M.D., M.S., Norbert Gleicher, M.D. 
In vitro sildenafil citrate use as a sperm motility stimulant
Soluble HLA-G in the peritoneal fluid of women with endometriosis
Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy  Eman A. Elgindy,
Contact among families who share the same sperm donor
Endometrial polyps affect uterine receptivity
The follicular and endocrine environment in women with endometriosis: local and systemic cytokine production  Antonio Pellicer, M.D., Carmela Albert,
In vitro viability and secretory capacity of human luteinized granulosa cells after gonadotropin-releasing hormone agonist trigger of oocyte maturation 
Marita Pall, M. D. , Ph. D. , Margaret Nguyen, B. S
P-24 Fertility and Sterility Volume 85, Pages S19-S20 (April 2006)
Logarithmic curves depicting initial level and rise of serum beta human chorionic gonadotropin and live delivery outcomes with in vitro fertilization:
Presentation transcript:

Endocrine disruptors and human reproductive failure: the in vitro effect of phthalates on human luteal cells  Federica Romani, M.D., Anna Tropea, M.D., Ph.D., Elisa Scarinci, M.D., Alex Federico, M.D., Cinzia Dello Russo, M.D., Ph.D., Lucia Lisi, Ph.D., Stefania Catino, M.L.T., Antonio Lanzone, M.D., Rosanna Apa, M.D., Ph.D.  Fertility and Sterility  Volume 102, Issue 3, Pages 831-837 (September 2014) DOI: 10.1016/j.fertnstert.2014.05.041 Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Effect of di-(2-ethylhexyl) phthalate (DEHP), n-butyl benzyl phthalate (BBP), and di-n-butyl phthalate (DBP) on basal P4 release by human luteal cells. Luteal cells were cultured for 24 hours in medium alone (control), or with hGC (100 ng/mL), or DEHP (10–6, 10–7, 10–8, 10–9 M), or BBP (10–6, 10–7, 10–8, 10–9 M), or DBP (10–6, 10–7, 10–8, 10–9 M). Each value represents the mean ± SD of nine independent experiments, each done in triplicate. Results are expressed as a percentage of the control set equal to 100. ∗∗∗P<.001; ∗∗P<.01; ∗P<.05 vs. control values. Fertility and Sterility 2014 102, 831-837DOI: (10.1016/j.fertnstert.2014.05.041) Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Effect of di-(2-ethylhexyl) phthalate (DEHP), n-butyl benzyl phthalate (BBP), and di-n-butyl phthalate (DBP) on P4-inducted hCG release by human luteal cells. Luteal cells were cultured for 24 hours in medium alone (control) or with hGC (100 ng/mL), or hGC (100 ng/mL) with DEHP added after 1 hour (10–6, 10–7, 10–8, 10–9 M), or BBP (10–6, 10–7, 10–8, 10–9 M), or DBP (10–6, 10–7, 10–8, 10–9 M). Each value represents the mean ± SD of nine independent experiments, each done in triplicate. Results are expressed as percentage of control set equal to 100. °°°P<.001 vs. C values; ∗∗∗P<.001 and ∗∗P<.01 vs. hCG values. Fertility and Sterility 2014 102, 831-837DOI: (10.1016/j.fertnstert.2014.05.041) Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions

Figure 3 Effect of di-(2-ethylhexyl) phthalate (DEHP), n-butyl benzyl phthalate (BBP), and di-n-butyl phthalate (DBP) on basal PGE2 release by human luteal cells. Luteal cells were cultured for 24 hours in medium alone (control) or with DEHP (10–6, 10–7, 10–8, 10–9 M), or BBP (10–6, 10–7, 10–8, 10–9 M), or DBP (10–6, 10–7, 10–8, 10–9 M). Each value represents the mean ± SD of seven independent experiments, each done in triplicate. Results are expressed as percentage of control set equal to 100. ∗∗∗P<.001; ∗∗P<.01; ∗P<.05 vs. control values. Fertility and Sterility 2014 102, 831-837DOI: (10.1016/j.fertnstert.2014.05.041) Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions

Figure 4 Effect of di-(2-ethylhexyl) phthalate (DEHP), n-butyl benzyl phthalate (BBP), and di-n-butyl phthalate (DBP) on basal VEGF release by human luteal cells. Luteal cells were cultured for 24 hours in medium alone (control) or with CoCl2 (10 μM) or with DEHP (10–6, 10–7, 10–8, 10–9 M), or BBP (10–6, 10–7, 10–8, 10–9 M), or DBP (10–6, 10–7, 10–8, 10–9 M). Each value represents the mean ± SD of 10 independent experiments, each done in triplicate. Results are expressed as percentage of control set equal to 100. ∗∗∗P<.001; ∗∗P<.01 vs. control values. Fertility and Sterility 2014 102, 831-837DOI: (10.1016/j.fertnstert.2014.05.041) Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions